These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23100524)

  • 1. Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: yes.
    Brassat D; Lebrun-Frenay C;
    Mult Scler; 2012 Nov; 18(11):1531-2. PubMed ID: 23100524
    [No Abstract]   [Full Text] [Related]  

  • 2. Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: no.
    Bourdette D; Yadav V
    Mult Scler; 2012 Nov; 18(11):1529-30. PubMed ID: 23100523
    [No Abstract]   [Full Text] [Related]  

  • 3. Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: commentary.
    Hutchinson M
    Mult Scler; 2012 Nov; 18(11):1533. PubMed ID: 23100525
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes.
    Rudick RA; Fisher E
    Mult Scler; 2013 Jul; 19(8):1003-4. PubMed ID: 23818018
    [No Abstract]   [Full Text] [Related]  

  • 5. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: yes.
    Saidha S; Calabresi PA
    Mult Scler; 2014 Sep; 20(10):1296-8. PubMed ID: 25160122
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
    Moore F; Okuda DT
    Neurology; 2009 Nov; 73(20):1714. PubMed ID: 19918002
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs.
    Sormani MP; Bonzano L; Roccatagliata L; De Stefano N
    Mult Scler; 2011 May; 17(5):630-3. PubMed ID: 21177320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes.
    Calabrese M; De Stefano N
    Mult Scler; 2014 Apr; 20(5):537-8. PubMed ID: 24692503
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiologically isolated syndrome: a clinical and therapeutic dilemma].
    García-Estévez DA
    Rev Neurol; 2012 Jul; 55(1):61-2. PubMed ID: 22718410
    [No Abstract]   [Full Text] [Related]  

  • 10. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
    Frohman EM; Havrdova E; Lublin F; Barkhof F; Achiron A; Sharief MK; Stuve O; Racke MK; Steinman L; Weiner H; Olek M; Zivadinov R; Corboy J; Raine C; Cutter G; Richert J; Filippi M
    Arch Neurol; 2006 Apr; 63(4):614-9. PubMed ID: 16606781
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Marburg variant multiple sclerosis with mitoxantrone.
    Jeffery DR; Lefkowitz DS; Crittenden JP
    J Neuroimaging; 2004 Jan; 14(1):58-62. PubMed ID: 14748210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpartum activation of multiple sclerosis: MRI imaging and immunological characterization of a case.
    Saraste MH; Kurki T; Airas LM
    Eur J Neurol; 2006 Jan; 13(1):98-9. PubMed ID: 16420404
    [No Abstract]   [Full Text] [Related]  

  • 13. [What can be expected from brain MRI in early-stage multiple sclerosis?].
    Grimaud J; Hermier M; Rovaris M
    Rev Neurol (Paris); 2001 Jan; 157(1):13-9. PubMed ID: 11240544
    [No Abstract]   [Full Text] [Related]  

  • 14. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
    Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
    Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
    Cadavid D; Wolansky LJ; Skurnick J; Lincoln J; Cheriyan J; Szczepanowski K; Kamin SS; Pachner AR; Halper J; Cook SD
    Neurology; 2009 Jun; 72(23):1976-83. PubMed ID: 19279320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy.
    Miravalle A; Jensen R; Kinkel RP
    Arch Neurol; 2011 Feb; 68(2):186-91. PubMed ID: 20937940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.
    Moraal B; Pohl C; Uitdehaag BM; Polman CH; Edan G; Freedman MS; Hartung HP; Kappos L; Miller DH; Montalban X; Lanius V; Sandbrink R; Barkhof F
    Arch Neurol; 2009 Nov; 66(11):1345-52. PubMed ID: 19901165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: no.
    Jenkins TM; Toosy AT
    Mult Scler; 2014 Sep; 20(10):1299-301. PubMed ID: 25160123
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and management of multiple sclerosis: case studies.
    Woo DA; Olek MJ; Frohman EM
    Neurol Clin; 2006 May; 24(2):199-214. PubMed ID: 16684629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria.
    Sedani S; Lim MJ; Hemingway C; Wassmer E; Absoud M
    Mult Scler; 2012 May; 18(5):679-82. PubMed ID: 22013145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.